Flovent, a popular steroid inhaler used to treat and control asthma symptoms in children and adults, is being discontinued next week as its manufacturer prepares to roll out a generic version of the ...
Starting January 1, a drug that thousands of patients depend on to help them breathe will disappear from pharmacy shelves, and doctors are concerned patients may have delays switching to alternatives ...
Flovent, a popular corticosteroid inhaler used to treat asthma, is no longer available. The global manufacturer, Glaxo Smith Kline (GSK), announced in May that the medications — Flovent HFA, a metered ...
As of Jan. 1, thousands of asthma patients in the U.S. will no longer be able to get refills for Flovent — one of the most popular inhalers in the U.S. for nearly 30 years. Flovent’s manufacturer, GSK ...
Editor’s Note: Dr. Edith Bracho-Sanchez is a primary care pediatrician, director of pediatric telemedicine and assistant professor of pediatrics at Columbia University Irving Medical Center. Flovent, ...
ATLANTA - Prices are rising sharply on many asthma inhalers just in time for spring allergy season and some insurance companies are not covering the higher costs, and many patients cannot afford the ...
The situation is an ironic one. While climate change is worsening respiratory illnesses — by increasing extreme heat, spreading smoke from wildfires, and lowering air quality — one of the most common ...
Please provide your email address to receive an email when new articles are posted on . Single-inhaler triple therapy with the extra-fine formulation of beclometasone, formoterol fumarate and ...
Starting Saturday, the cost of inhalers will fall for many Americans, as new out-of-pocket price caps go into effect for the asthma medications from AstraZeneca and Boehringer Ingelheim. Following ...
If there is any field of science that understands the doctrine of unintended consequences, it’s medicine. We rely on antibiotics to wipe out infections, and in the process breed a class of superbugs ...
Cipla, which was recently hit with a 23-page Form 483 filing from the FDA, is adding to the albuterol supply strain with a U.S. recall of six batches of the asthma med. The company's voluntary recall ...
Inhaler use is producing millions of metric tonnes of emissions and having a big impact on global warming, a new study has suggested. The findings, published in journal JAMA, found inhaler-related ...